Phosphorus
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Summary
Phosphorus is a medication indicated in the treatment of hypophosphatemia.
- Generic Name
- Phosphorus
- DrugBank Accession Number
- DB14151
- Background
Not Available
- Type
- Small Molecule
- Groups
- Approved, Experimental
- Structure
- Weight
- Average: 30.9738
Monoisotopic: 30.973761512 - Chemical Formula
- P
- Synonyms
- Phosphorous
- Phosphorus, elemental
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
- Associated Therapies
- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- No interactions found.
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Advanced B & T Formula Phosphorus (100 mg) + Ascorbic acid (33.3 mg) + Calcium (200 mg) + Chromium (33.33 mcg) + Copper (0.5 mg) + Cyanocobalamin (6.67 mcg) + Folic acid (0.133 mg) + Iron (1.67 mg) + Magnesium (83.3 mg) + Manganese (3.33 mg) + Nicotinamide (6.67 mg) + Calcium pantothenate (5 mg) + Potassium (16.67 mg) + Pyridoxine hydrochloride (6.67 mg) + Riboflavin (2.67 mg) + Selenium (33.33 mcg) + Silicon (0.333 mg) + Sodium molybdate (16.67 mcg) + Thiamine (2.67 mg) + Vanadium (8.33 mg) + Vitamin D (66.67 unit) + Zinc (5 mg) Capsule Oral Nutraceutical Corporation Not applicable Not applicable Canada Anaplex Tab Phosphorus (75.33 mg / tab) + Ascorbic acid (40 mg / tab) + Calcium (160 mg / tab) + Iodine (.05 mg / tab) + Magnesium oxide (50 mg / tab) + Nicotinamide (30 mg / tab) + Calcium pantothenate (15 mg / tab) + Potassium chloride (20 mg / tab) + Pyridoxine hydrochloride (40 mg / tab) + Vitamin A palmitate (2000 unit / tab) + Vitamin D (133.33 unit / tab) Tablet Oral Anabolic Laboratories Inc. 1975-12-31 1996-10-02 Canada Calci A and D Tab Phosphorus (70 mg) + Calcium (165 mg) + Vitamin A (1000 unit) + Vitamin D (100 unit) Tablet Oral Pharmetics (2011) Inc. 1981-12-31 2006-07-27 Canada Calcium Phosphorus & Vitamin D Phosphorus (97 mg / tab) + Calcium (215 mg / tab) + Vitamin D (100 unit / tab) Tablet Oral Avacare, Division Of Jeunique International Inc. 1985-12-31 1996-09-09 Canada Chelamins Plus Tab Phosphorus (75 mg) + Calcium (350 mg) + Chromium (50 mcg) + Copper (1.5 mg) + Iodine (.15 mg) + Iron (15 mg) + Magnesium (175 mg) + Manganese (5 mg) + Potassium (47.5 mg) + Selenium (25 mcg) + Vitamin D (200 unit) + Zinc (11.25 mg) Tablet Oral Nu Life Nutrition Ltd. 1988-12-31 2000-03-03 Canada Complete One A Day Tab Phosphorus (125 mg) + Ascorbic acid (150 mg) + Biotin (52 mcg) + Calcium (125 mg) + Choline bitartrate (52 mg) + Chromium (25 mcg) + Copper (1 mg) + Cyanocobalamin (52 mg) + Ergocalciferol (400 unit) + Folic acid (.2 mg) + Inositol (52 mg) + Iodine (.1 mg) + Iron (15 mg) + Magnesium (50 mg) + Manganese (1 mg) + Niacin (52 mg) + Calcium pantothenate (52 mg) + Potassium (50 mg) + Racemethionine (52 mg) + Riboflavin (52 mg) + Selenium (25 mcg) + Thiamine hydrochloride (52 mg) + Vitamin A palmitate (10000 unit) + Vitamin E (50 unit) + Zinc (10 mg) Tablet Oral Canat Laboratories Inc. 1996-12-31 1999-08-28 Canada DECAVIT PRONATAL FILM KAPLI TABLET, 30 ADET Phosphorus (125 mg) + Ascorbic acid (100 mg) + Biotin (200 pg) + Calcium (125 mg) + Cyanocobalamin (4 μg) + Ergocalciferol (500 IU) + Folic acid (0.8 mg) + Iron (60 mg) + Magnesium (100 mg) + Manganese (1 mg) + Nicotinamide (19 mg) + Calcium pantothenate (10 mg) + Pyridoxine hydrochloride (2.6 mg) + Riboflavin (1.8 mg) + Thiamine hydrochloride (1.6 mg) + Vitamin A (4000 IU) + Vitamin E (15 mg) + Zinc (7.5 mg) Tablet KOÇAK FARMA İLAÇ VE KİMYA SAN. A.Ş. 2020-08-14 Not applicable Turkey DECAVIT PRONATAL FILM KAPLI TABLET, 60 ADET Phosphorus (125 mg) + Ascorbic acid (100 mg) + Biotin (200 pg) + Calcium (125 mg) + Cyanocobalamin (4 μg) + Ergocalciferol (500 IU) + Folic acid (0.8 mg) + Iron (60 mg) + Magnesium (100 mg) + Manganese (1 mg) + Nicotinamide (19 mg) + Calcium pantothenate (10 mg) + Pyridoxine hydrochloride (2.6 mg) + Riboflavin (1.8 mg) + Thiamine hydrochloride (1.6 mg) + Vitamin A (4000 IU) + Vitamin E (15 mg) + Zinc (7.5 mg) Tablet KOÇAK FARMA İLAÇ VE KİMYA SAN. A.Ş. 2020-08-14 Not applicable Turkey DECAVIT YUMUSAK KAPSUL, 30 ADET Phosphorus (125 mg) + Ascorbic acid (100 mg) + Biotin (200 pg) + Calcium (125 mg) + Cyanocobalamin (4 μg) + Ergocalciferol (500 IU) + Folic acid (0.8 mg) + Iron (60 mg) + Magnesium (100 mg) + Manganese (1 mg) + Nicotinamide (19 mg) + Calcium pantothenate (10 mg) + Pyridoxine hydrochloride (2.6 mg) + Riboflavin (1.8 mg) + Thiamine hydrochloride (1.6 mg) + Vitamin A (4000 IU) + Vitamin E (15 mg) + Zinc (7.5 mg) Capsule KOÇAK FARMA İLAÇ VE KİMYA SAN. A.Ş. 2020-08-14 Not applicable Turkey Elevit pronatal - Filmtabletten Phosphorus (125 mg) + Ascorbic acid (100 mg) + Biotin (0.2 mg) + Calcium (125 mg) + Cholecalciferol (500 IU) + Copper (1 mg) + Cyanocobalamin (4 mcg) + Folic acid (0.8 mg) + Iron (60 mg) + Magnesium (100 mg) + Manganese (1 mg) + Nicotinamide (19 mg) + Calcium pantothenate (10 mg) + Pyridoxine hydrochloride (2.6 mg) + Riboflavin (1.8 mg) + Thiamine mononitrate (1.55 mg) + Vitamin A palmitate (3600 IU) + Zinc (7.5 mg) + alpha-Tocopherol acetate (15 IU) Tablet, film coated Oral Bayer Austria Gmb H 1994-01-13 Not applicable Austria
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 27YLU75U4W
- CAS number
- 7723-14-0
- InChI Key
- OAICVXFJPJFONN-UHFFFAOYSA-N
- InChI
- InChI=1S/P
- IUPAC Name
- phosphorus
- SMILES
- [P]
References
- General References
- TITCK: Megadyn Pronatal (Multivitamin) Oral Tablet [Link]
- External Links
- Human Metabolome Database
- HMDB0001315
- ChemSpider
- 4575369
- 8263
- ChEBI
- 30207
- Wikipedia
- Phosphorus
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Recruiting Treatment X-Linked Hypophosphatemia 1 3 Unknown Status Treatment Chronic Kidney Disease (CKD) 1 2, 3 Completed Treatment Overweight / Pregnancy / Psychiatric Disorder NOS 1 1, 2 Completed Treatment Dent's Disease 1 Not Available Completed Not Available Chronic Kidney Disease (CKD) 1 Not Available Unknown Status Prevention White Spot Lesion of Tooth 1 Not Available Unknown Status Supportive Care Secondary Hyperparathyroidism (SHPT) 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Tablet, film coated Oral Tablet Capsule Tablet Oral Liquid Oral Capsule Oral Capsule, gelatin coated Oral Powder Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source logP 0.3 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 0 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 0 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 5.2 m3·mol-1 Chemaxon Polarizability 1.78 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available
Drug created at June 28, 2018 19:42 / Updated at May 14, 2021 01:06